Related Experiment Video
Updated: Dec 6, 2025
07:01
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
9.3K
Interleukin 4 Affects Epilepsy by Regulating Glial Cells: Potential and Possible Mechanism
1Department of Neurology, First Affiliated Hospital, Kunming Medical University, Kunming, China.
Frontiers in Molecular Neuroscience
|October 5, 2020
Summary
Interleukin 4 (IL-4) may protect against epilepsy by regulating brain inflammatory cells like microglia and astrocytes. This suggests IL-4 could be a new therapeutic target for treating epilepsy.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Epilepsy is a chronic brain disorder characterized by abnormal neuronal discharges.
- Inflammation, particularly involving microglia and astrocytes in the central nervous system (CNS), is increasingly linked to epilepsy pathogenesis.
- Interleukin 4 (IL-4) is identified as a key anti-inflammatory factor with regulatory effects on glial cells.
Purpose of the Study:
- To review the regulatory role of IL-4 in the pathological changes of glial cells associated with epilepsy.
- To explore the potential protective effects of IL-4 in epileptogenesis.
- To propose IL-4 as a novel therapeutic target for epilepsy treatment.
Main Methods:
- Literature review focusing on studies investigating the interplay between IL-4, glial cells, and epilepsy.
- Analysis of existing research on the anti-inflammatory functions of IL-4 in the CNS.
- Synthesis of evidence regarding IL-4's impact on microglia and astrocyte activity in epilepsy models.
Main Results:
- IL-4 demonstrates regulatory functions over microglia and astrocytes, key inflammatory cells in the CNS.
- Evidence suggests a connection between IL-4's anti-inflammatory actions and the modulation of epilepsy development.
- The anti-inflammatory properties of IL-4 appear to influence pathological glial cell changes relevant to epilepsy.
Conclusions:
- IL-4 plays a significant role in regulating glial cell responses in the context of epilepsy.
- IL-4 exhibits a potential protective effect against the development and progression of epilepsy (epileptogenesis).
- IL-4 represents a promising novel therapeutic target for future epilepsy treatments.
Related Concept Videos
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.0K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.0K
01:24Epilepsy and Seizures: Overview
991
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
991
01:14Antiepileptic Drugs: Glutamate Antagonists
748
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
748
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
670
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
670
01:20Antiepileptic Drugs: Potassium Channel Activators
487
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
487
01:17Antiepileptic Drugs: Calcium Channel Blockers
947
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
947